Company Filing History:
Years Active: 2024
Title: Lilia Boucinha: Innovator in Fecal Microbiota Research
Introduction
Lilia Boucinha is a prominent inventor based in Lyons, France. She has made significant contributions to the field of microbiota research, particularly in the context of treatment-induced inflammation. Her innovative work has the potential to impact the medical community and improve patient outcomes.
Latest Patents
Lilia Boucinha holds a patent titled "Fecal microbiota composition for use in reducing treatment-induced inflammation." This invention relates to the use of fecal microbiota transplant for preventing and/or reducing systemic and gut treatment-induced inflammation in individuals in need thereof. She has 1 patent to her name, showcasing her dedication to advancing medical science.
Career Highlights
Lilia is associated with Maat Pharma, a company focused on developing innovative therapies. Her work at Maat Pharma emphasizes the importance of microbiota in health and disease management. Through her research, she aims to provide new solutions for patients suffering from inflammation due to medical treatments.
Collaborations
Lilia collaborates with talented professionals in her field, including Emilie Plantamura and Cyrielle Gasc. These collaborations enhance her research efforts and contribute to the development of effective therapies.
Conclusion
Lilia Boucinha is a trailblazer in the field of fecal microbiota research, with a focus on reducing treatment-induced inflammation. Her innovative patent and work at Maat Pharma highlight her commitment to improving healthcare solutions.